Tompkins Financial Corp Takes Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tompkins Financial Corp acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 1,864 shares of the company’s stock, valued at approximately $151,000.

Other large investors have also recently bought and sold shares of the company. Gradient Investments LLC purchased a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $37,000. Peoples Financial Services CORP. acquired a new position in GE HealthCare Technologies in the second quarter valued at approximately $64,000. Worth Asset Management LLC purchased a new position in GE HealthCare Technologies in the second quarter valued at approximately $83,000. Boit C F David acquired a new stake in GE HealthCare Technologies during the second quarter worth approximately $102,000. Finally, Piscataqua Savings Bank purchased a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth approximately $119,000. Hedge funds and other institutional investors own 79.18% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC traded down $0.62 during trading on Tuesday, hitting $65.66. The stock had a trading volume of 518,432 shares, compared to its average volume of 3,077,064. The company has a debt-to-equity ratio of 1.44, a quick ratio of 0.92 and a current ratio of 1.22. GE HealthCare Technologies Inc. has a twelve month low of $53.00 and a twelve month high of $87.83. The company’s 50-day moving average price is $73.08 and its 200 day moving average price is $77.01.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Tuesday, July 25th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.87 by $0.05. The firm had revenue of $4.82 billion for the quarter, compared to analyst estimates of $4.79 billion. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 3.8 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Friday, July 21st were issued a $0.03 dividend. The ex-dividend date was Thursday, July 20th. This represents a $0.12 annualized dividend and a dividend yield of 0.18%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Kevin Michael O’neill sold 15,609 shares of the stock in a transaction on Monday, July 31st. The stock was sold at an average price of $77.32, for a total value of $1,206,887.88. Following the completion of the transaction, the chief executive officer now owns 24,025 shares in the company, valued at $1,857,613. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.21% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the topic of several research analyst reports. Morgan Stanley initiated coverage on shares of GE HealthCare Technologies in a research note on Tuesday, June 27th. They set an “equal weight” rating on the stock. Argus initiated coverage on GE HealthCare Technologies in a report on Friday, August 25th. They issued a “buy” rating and a $80.00 target price for the company. Wells Fargo & Company assumed coverage on GE HealthCare Technologies in a research note on Wednesday, August 16th. They set an “overweight” rating and a $90.00 price target on the stock. Citigroup assumed coverage on GE HealthCare Technologies in a research note on Tuesday. They issued a “buy” rating and a $82.00 price objective for the company. Finally, Bank of America began coverage on shares of GE HealthCare Technologies in a research report on Monday, July 31st. They set a “neutral” rating and a $82.00 target price on the stock. Five research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $88.44.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.